Related Experiment Video
Updated: Mar 21, 2026
In vivo Imaging Method to Distinguish Acute and Chronic Inflammation
Published on: August 16, 2013
Repair Mechanisms in Oxidant-Driven Chronic Inflammatory Disease
1Department of Bioengineering, University of Bridgeport, Bridgeport, Connecticut.
Abstract:
The interplay that governs chronic diseases through pathways specifically associated with chronic inflammation remains undefined. Many metabolic events have been identified during the injury and repair process. Nonetheless, the cellular events that control the pathogenesis of inflammation-induced disease have not been fully characterized. We and others reason that chronic inflammatory diseases associated with a cascade of complex network mediators, such as nitric oxide, arachidonic acid metabolites, cytokines, and reactive oxygen species, play a significant role in the governance of alterations in homeostasis, oxidative stress, and thromboatherosclerosis. In this context, we discuss lipid mediators associated with the maintenance of health, including the specialized proresolving mediators that help drive cellular repair. Emphasis is placed on the pathophysiology of chronic metabolic insults involving both the airways and the cardiovascular system during oxidant-driven inflammatory disease. In this review, we highlight new pathways of inquiry that show promise for the identification of those metabolic targets that can improve therapy for chronic inflammation.
Insights
Chronic inflammation underlies many diseases, but the exact cellular mechanisms are unclear. Research is exploring metabolic targets and specialized proresolving mediators for improved therapies against inflammation-induced conditions.
Area of Science:
- Biomedical Science
- Pathophysiology
- Metabolic Research
Background:
- Chronic inflammation's role in disease pathogenesis is complex and not fully understood.
- Key mediators like nitric oxide, cytokines, and reactive oxygen species are implicated in disease.
- The cellular events controlling inflammation-induced diseases require further characterization.
Purpose of the Study:
- To define the interplay governing chronic diseases via inflammation.
- To explore the role of lipid mediators, including specialized proresolving mediators, in health and disease.
- To highlight novel pathways for identifying metabolic targets to improve chronic inflammation therapy.
Main Methods:
- Review of existing literature on chronic inflammation and metabolic pathways.
- Analysis of cellular events in inflammation-induced diseases.
- Discussion of oxidant-driven inflammatory disease pathophysiology.
Main Results:
- Chronic inflammatory diseases involve complex mediator cascades affecting homeostasis, oxidative stress, and thromboatherosclerosis.
- Specialized proresolving mediators play a role in cellular repair.
- New pathways offer promise for identifying therapeutic metabolic targets.
Conclusions:
- Understanding the cellular and metabolic underpinnings of chronic inflammation is crucial.
- Targeting specific metabolic pathways and lipid mediators may offer new therapeutic strategies.
- Further research into oxidant-driven inflammation is needed for effective treatment of chronic diseases.
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
01:28Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
01:20Radical Autoxidation
01:38Inflammation
01:26Coronary Artery Disease II: Pathophysiology
01:24Chronic Pancreatitis I: Introduction
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...